“…In total, we identified a 3110-non-redundant protein data set, which, to our knowledge, is the most comprehensive one to date. To internally validate our approach, we observed among our top candidates, 12 proteins (MGAT5, PAM, GBA, ROBO1, CD59, MMP1, IGFBP4, CDH2, TGFB2, ICAM1, EPHA2, and IGFBP5) that have previously been studied or implicated in prostate cancer progression (22)(23)(24)(25)(26)(27)(28)(29)(30)(31)(32)(33). For example, MGAT5 has been shown to mediate enhanced invasion and metastatic potential for prostate cancer cells through many in vitro invasion assays and xenograft animal models.…”